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Abstract.  Interferons, in addition to their antiviral ac- 
tivity, induce a multiplicity of effects on different cell 
types. Interferon (IFN)-3,  exerts a unique regulatory 
effect on cells of the mononuclear phagocyte lineage. 
To investigate whether the antiviral and antiprolifera- 
tive effects of IFN-~ in macrophages can be geneti- 
caUy dissociated, and whether IFN-ot and IFN-3, use 
the same cellular signals and/or effector mechanisms 
to achieve their biologic effects, we have derived a se- 
ries of somatic cell genetic variants resistant to the an- 
tiproliferative and/or antiviral activities of IFN-3,.  Two 
different classes of variants were found: those resistant 
to the antiproliferative and antiviral effects of IFN-'t 
against vesicular stomatitis virus (VSV) and those 
resistant to the antiproliferative effect, but protected 
against VSV and encephalomyocarditis virus (EMCV) 
lysis by IFN-~. In addition, a third class of mutants 
was obtained that was susceptible to the growth inhibi- 
tory activity, but resistant to the antiviral activity of 
IFN-7. Analysis of these mutants has provided several 
insights regarding the regulatory mechanisms of IFN-3, 
and IFN-o~ on the murin¢ macrophage cell lines. The 
antiproliferative activity of IFN-3,  on these cells, in 
contrast to that of IFN-ot,  is mediated by a 
cAMP-independent pathway.  The antiproliferative and 
antiviral activities of IFN-3, were genetically dis- 
sociated. Variants  were obtained that are growth resis- 
tant but antivirally protected, or are growth inhibited 
but not antivirally protected against VSV or EMCV. 
The genetic analysis indicated that IFN-~ and IFN--y 
regulate the induction of the dsRNA-dependent P1/eIF- 
2a protein kinase and 2',5'-oligoadenylate synthetase 
enzymatic activities via different pathways. Finally, a 
unique macrophage mutant was obtained that was pro- 
tected by IFN-'y against infection by VSV, but not 
EMCV, suggesting that antiviral mechanisms involved 
in protection against these different types of RNA 
viruses must be distinct at some level. 
I 
NTERFERONS (IFNs) ~ are defined as molecules that in- 
duce an antiviral  state,  but in addition are known to 
exert a multiplicity of effects on a variety of different cell 
types, including the inhibition  of cell proliferation  07, 24, 
35, 47). Of the three classes of IFN known, IFN-a and IFN- 
/3 share a common cell receptor while IFN-7 binds to a dis- 
tinct cell receptor (5).  Two unique interferon-induced en- 
zyme activities have been implicated in the antiviral effects 
of IFN-ot and IFN-/3, namely,  the P1/eukaryotic initiation 
factor-2ot (P1/eIF-2ot) protein kinase and 2',5 '-oligoadenylate 
synthetase (2',5'-(A)n synthetase) systems (reviewed in 28, 
36), but it is unknown whether similar mechanisms are 
used by IFN-'y.  While IFN-ot and IFN--y elicit common 
cellular responses in many cell types, IFN-), has specific 
effects on cells of the mononuclear phagocyte lineage. 
IFN-'r  can increase Fc receptor-mediated phagocytosis 
(38),  induce the expression of major histocompatibility 
L  Abbreviations  used in this paper: elF-2, eukaryotic initiation factor-2; 
EMCV,  encephaiomyocarditis  virus;  G i,  growth  inhibited;  G  r,  growth 
resistant;  IFN, interferon;  2',5'-(A)n,  2',5'-oligoadenylate; VP, antivirally 
protected;  V  s, susceptible to viral lysis. 
complex class I and class II antigens (23, 46), and activate 
macrophages to produce a respiratory burst after endocy- 
tosis of bacteria or parasites (34). Electrophoretic analy- 
sis of polypeptides derived from IFN-,y-treated human 
fibroblast lines revealed that at least 12 unique proteins 
are induced by IFN-~/(50). The molecular mechanisms 
of the antiproliferative and antiviral effects of interferon, 
or the unique activation of macrophages by IFN-'t remain 
largely unknown. 
One approach to understanding the mechanisms by which 
IFNs, and in particular IFN-% act to regulate mononuclear 
phagocyte function is a somatic cell genetic analysis using 
cloned macrophage cell lines.  In previous  studies  we ob- 
served that macrophage variants in cAMP metabolism of the 
J774.2 murine macrophage cell line were 50-fold less sensi- 
tive to the antiproliferative effects of IFN-ot than the parental 
clone (43). Conversely, a role for cAMP was confirmed by 
selecting  for IFN-ot-resistant  mutants,  five of which were 
shown to have defective  adenylate cyclase, providing genetic 
evidence that IFN-ot uses a cAMP-dependent  signal trans- 
duction mechanism in mediating the antiproliferative effects 
in at least one type of cell (33). The antiviral state was fully 
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demonstrating that it was possible genetically to dissociate 
the antiviral  and antiproliferative  effects of IFN-o~. 
Because IFN-'y is known to have unique effects in regulat- 
ing macrophage function, as well as inducing the antiviral 
and antiproliferative effects on macrophage  cell  lines,  we 
have attempted here to investigate two questions: (a) whether 
one can genetically dissociate the antiviral and antiprolifera- 
tive effects oflFN-3,, as in the case of IFN-t~; and (b) whether 
IFN-ot and IFN-~/use the same cellular signals and/or effec- 
tor mechanisms to achieve these biological effects. 
Materials and Methods 
Cells 
The cloned cell line, J774.2, was originally established from a mouse retic- 
ulum cell sarcoma derived by P.  Ralph et al.  (39) and shown to have a 
macrophage-like phenotype (4, 32). J774.2 and variant clones were main- 
tained in DME, supplemented with 20% heat-inactivated horse serum, 0.1 
mM nonessential amino acids (NEAA), 10% NCTC 109 conditioned media 
(Microbiological Associates, Walkersviile, MD), penicillin, and streptomy- 
cin at 37°C in a humid incubator containing 7% CO2. 
The mouse bepatoma cell line, E3, was grown in DME supplemented 
with 10% heat-inactivated FCS, 5% NCTC  109, and 1% NEAA. Primary 
rat embryo fibroblasts were cultured in DME supplemented with 10 % FCS. 
DME, horse and fetal calf serum, NEAA, penicillin, and streptomycin were 
from Gibco Laboratories, Grand Island, NY. 
Viruses 
The Indiana serotype of vesicular stomatitis virus (VSV) was prepared in 
chicken embryo fibroblasts, clarified by centrifugation (1,000 g,  10 min), 
and had a titer of 3.0 ×  l0  s pfu/ml. The stock was divided into small por- 
tions, frozen at  -70°C, and diluted into regular macrophage cell culture 
medium before use.  Encephalomyocarditis virus (EMCV) was obtained 
from J. Paucker (University of Pennsylvania, Philadelphia, PA) and had a 
titer of 5  x  107 pfu/mi. 
Interferon 
Recombinant Escherichia coil-derived murine IFN-'y (Genentech Inc., San 
Francisco, CA) had a specific activity of 1.24  x  107 U/rag. Murine IFN-cx 
was obtained from Lee Biomolecular Company (catalogue No. 22061;  San 
Diego, CA) and had a specific activity of 2.7 ×  106 U/mg. Interferon activ- 
ity was assayed by the inhbition of cytopathic effects of EMCV on L cells 
in microtiter wells. Interferon activity was routinely titered once a month 
to determine if any loss of activity had occurred. 
Cloning of  Macrophage Lines 
Macrophage cell lines and variants were cloned in Sea plaque ngarose (FMC 
Corporation, Rockland, ME) on a rat embryo fibroblast or E3 feeder layer. 
A  1:20 dilution of a confluent layer of feeder cells was plated 18 h before 
cloning in a 60-ram tissue culture dish (Falcon Labware, Oxnard, CA). 16 h 
later the medium was aspirated off and 4 ml of medium plus agarose (final 
concentration 0.45% [wt/vol]) was allowed to solidify at 4°C for 10 rain. 
Macrophage cell suspension was diluted 1:10 with medium plus agarose and 
I ml of cell suspension was layered on top of the solidified agarose. After 
10 min at 4"C the cells were placed in a 37"C incubator at 7% CO2. Mac- 
rophage colonies were picked 7-9 d later. 
Selection of  lFN-resistant Variants 
J774.2 cells were cloned in 4,000 U/ml of IFN-3' without prior mutagenesis. 
The clones were then grown in increasing concentrations of IFN-3' from 500 
to 4,000 U/ml over a 3-4-wk period. Clones able to grow in the presence 
of 4,000 U/ml of IFN-,'/were allowed to grow in cell culture in IFN-'r-free 
medium for a month and were then retested for their ability to grow in IFN-3,. 
A  spontaneous mutant was derived from J774.2 cells which were main- 
tained in culture for 1.5 yr, that was growth inhibited by IFN-3,,  although 
susceptible to viral iysis 0774.2-7  =  GINS). After the discovery that the 
culture was not as responsive vis-/t-vis the antiviral activity of IFN-% the 
cells were subcloned for isolated colonies and retested for their phenotype. 
Growth Curves 
Cells in log phase were seeded (7.5  x  103 cells/0.15 ml) in 96-well plates 
(Linbro, Flow Laboratories, Hamden, CT), in the absence or presence of 
the various IFNs and cholera toxin. At the time intervals indicated 0.025 
mi of tritiated thymidine at 0.04 mCi/ml was added per well (final concen- 
tration of l/~Ci/well). After a 45-min incubation 0.05 ml of 0.45% NP40 
in PBS was added per well for 5-10 min with moderate rotation on an orbital 
gyrator. Nuclei were harvested onto glass filter paper, dried, and counted 
with liquiscint for 1 min on a liquid scintillation counter. Results for each 
experimental point is the average of  triplicate wells. Individual wells did not 
differ generally >1 SD from the mean. Preliminary experiments showed that 
the inhibition of thymidine incorporation by IFN-ct and IFN-v paralleled 
the actual growth inhibition as measured by counting the number of viable 
cells excluding trypan blue with a hemocytometer. 
Viral Infection 
Cells (2-4  x  105) were plated in 2-cm  2 wells (Linbro) for 21 h in 1 ml of 
medium in the presence and absence of IFN. VSV or EMCV, at a multiplic- 
ity of infection of 0.1, was added and the cells cultured for an additional 
18-24 h. Supernatants were collected and stored frozen at  -700C. 
Viral Yield 
Serial 10-fold dilutions (0.2 ml) of the above supernatant fluids were added 
to confluent Veto cell monolayers in 2-cm  2 wells. After 1-h adsorption at 
37°C, 1 ml of warm medium containing 0.75%  carboxyi methyl cellulose 
was  added,  and  wells were incubated for an additional  36-48  h.  The 
monolayers were then fixed for 10 min, stained with crystal violet, and viral 
plaques counted. 
RNA Isolation 
For the preparation of cytoplasmic RNA, cells were harvested, either by 
pipetting or scraping them off the dish, then washed twice with cold PBS, 
and resuspended in 0.45 ml of ice-cold buffer containing 10 mM Tris HCI, 
1 mm EDTA, and 10 mM vanadyl nucleoside. Cells were lysed by adding 
0.05 rni of 5% NP-40 (final concentration 0.5%), incubated 5 min on ice, 
and then another 0.05 ml was added for an additional 5 min. The nuclei were 
centrifuged at 1,500 rpm for 5 rain and the superuatant was transferred into 
another tube. 2 vol of SDS buffer containing 200 mM Tris pH 9.0, 50 mM 
sodium chloride, 10 mM EDTA, and 0.5% SDS was added to a single vol- 
ume of superoatant. The supematant was deproteinized with phenol twice 
and then with chloroform isoamylalcohol. 0.1 vol of 3 M sodium acetate pH 
5.2 and 2.5 vol of 95% ethanol was added and the RNA was precipitated 
overnight at  -20°C. 
RNA Analysis 
RNA was analyzed by Northern blot analysis (14).  The human 2',SL(A), 
synthetase gene probe (clone 6-2) (42), was subcloned into pGEM for the 
production of riboprobes. Biodyne nylon blots were hybridized with T7 
riboprobes. Cytoplasmic RNA was blotted onto Biodyne filters and pre- 
hybridized for 4 b at 590C under the following conditions: 50% formamide, 
6x  SSC,  1% SDS, 0.1% Twcen 20,  100 ~tg/ml tRNA, and 10 mM DTT. 
Labeled RNA (106 cpm/ml) was added to the hybridization solution for an 
additional 18 h. The filters were washed once with 2x SSC and 0.1% SDS 
for 30 min at room temperature, then with 2x SSC and 0.1% SDS at 65°C, 
and finally 0.2x  SSC and 0.1%  SDS at 650C for 30 min. 
Gel Electrophoresis 
SDS (0.1%)-  10% PAGE was performed according to Laemmli (27).  Gels 
were  run  with  molecular  mess merkers  as  follows:  lysozyme  (Mr  = 
14,300),  ~-Iactoglobulin  (Mr  =  18,400),  ot-chymotrypsinogen (Mr  = 
25,700),  albumin (Mr  =  43,000),  bovine serum albumin (Mr -- 58000), 
phosphorylase B (Mr  =  97,400),  and myosin (H chain) (Mr -- 200D00). 
For analysis of proteins labeled with [35S]methionine,  the gel was impreg- 
nated with En3Hance, dried, and subjected to autoradiography at  -70°C. 
Assay of  2',Y-Oligoadenylate Synthetase Activity 
2',5'-(A), synthetase activity was assayed by methods previously described 
(18).  Cells  were cultured  for  20-21  h  with  or  without  500  IU/ml  of 
interferon-ct or -7. They were then extracted with 0.15%  NP-40, clarified 
by centrifugation, and the superuatant fluid frozen at  -70°C. 
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Figure I. Growth of the parental line, J774.2, in IFN-v and IFN-t~. 
Cells were plated in medium alone (e) or in varying concentrations 
of IFN--y  (A) or IFN-c~ (B). The results are presented as the average 
number of counts per minute (CPM) of tritiated thymidine (3H-TdR) 
incorporated from triplicate wells. 
Cell extracts were applied to polyI:polyC  agarose columns (P. L. Bio- 
chemicals,  Inc., Milwaukee, WI) and then equilibrated with 25 ml of 20 
mM Hepes pH 7.5, 90 mM KCi, 8.5 mM magnesium acetate, 7 mM beta- 
mercaptoethanol, and 20% glycerol. The agamse column was then washed 
three times with 100/~1 of cold reaction mixture containing the same buffer 
and 3 mM ATE 0.2% creatine phosphate, 0.03% creatine phosphokinase, 
followed by the same mixture containing purified 3H-ATP. The column was 
incubated at 30"C for 15 h and then the supernatant was boiled for 3 min 
to destroy any  nucleases.  The 2',5'-(A), was separated  from the uncon- 
verted ATP and DEAE columns by elution with 350 mM KCI at pH 7.5. 
Assay of  Double-stranded RNA-dependent PllelF-2a 
Protein Kinase Activity 
Cells were cultured for 21  h with or without IFN-7 (500 IU/ml) and then 
detergent extracts of cells were prepared as previously described (20). The 
reaction volume for the P1/eIF-2c~  protein kinase assay was 0.05 nd and con- 
tained 100 mM KCI, 5.0 mM beta-mercaploethanol,  10.0 mM magnesium 
chloride, 1 mm 32p-T-ATP at  104 cpm/pmol, 2 ~g/ml of double-stranded 
RNA (polyI:polyC),  and  100 t~g protein  from cell extracts.  Incubations 
were performed  at 30°C for 30 rain and phosphorylated proteins were ana- 
lyzed by gel electrophoresis. 
Results 
Description of  lFN Variants 
The initial question we wished to address was whether the 
antiviral and antiproliferative effects of IFN--y could be ge- 
netically dissociated, or were mediated by a common mecha- 
nism. IFN-7 exerts a powerful antiproliferative effect on the 
growth of ceUs of the J774.2 macropbage cell line (Fig. 1 A). 
Our approach to the question was to select variants of J774.2 
genetically resistant to the antiproliferative effects of IFN-3, 
by cloning the cells in 4,000 IU/ml of IFN-v without prior 
mutagenesis. The clones obtained were tested for their sensi- 
tivity to IFN-7 after growing 1 mo in IFN-7-free medium, 
and five clones resistant  to the antiproliferative effects of 
IFN-'t  were  isolated  in  two  independent  cloning experi- 
ments. The growth characteristics of some of these variants 
are illustrated in Fig. 2. Variants resistant to growth inhibi- 
tion by IFN-y were then analyzed for the induction of an an- 
tiviral state by IFN-'y as determined by reduction in yields 
of VSV  (Table I).  Two different classes  of variants  were 
found, based on their sensitivity to lysis by VSV after IFN-~, 
treatment: growth resistant to IFN--y/protected against VSV 
lysis (Gr/Vp);  and growth resistant to IFN-~,/susceptible to 
VSV  lysis  after IFN-3, treatment (G'/Vs).  G'/Vp variants, 
represented by J7-/R1,  J7-yRS, and J7"yR10 were protected 
against  VSV  infection.  Gr/V  s  variants,  represented  by 
J7~R5 and J73,R7 were susceptible to VSV lysis. Of particu- 
lar interest, one clone, J73,R5, that was susceptible to VSV 
was consistently protected by IFN-3, against the EMCV in- 
fection, and thus must have a functional IFN-3, receptor (Ta- 
ble II). A third class of variants, represented by a spontane- 
ous  mutant  of J774.2  which  arose  after  the  cells  were 
maintained for 1.5 yr in continuous culture, was susceptible 
to the antiproliferative effects of IFN-% but resistant to the 
antiviral effects. Cells growth inhibitable by IFN-3, yet sus- 
ceptible to viral lysis  (GVV  s)  are represented by J774.2-7 
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Figure 2. Effect oflFN-3, and IFN-ct on the growth 
of variant clones.  Cells were plated in medium 
alone (o) or in IFN-), and IFN-ot. Results of a rep- 
resentative experiment, which was reproduced-at 
least five times, are presented. Each point repre- 
sents the average counts per minute (CPM) of ti- 
trated thymidine (~H-TdR) incorporated from trip- 
licate wells. 
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Variant  Clones 
Reduction of VSV yields (pfu/ml) 
Reduction 
Clone  IFN-~, treatment  of pfu/ml 
IU/ral 
J774,2  10  103 
100  104 
1,000  104 
J7~/R1  10  104 
100  104 
1,000  104 
J73,R5  10  <10  l 
100  <101 
1,000  <101 
J73'R7  10  <10 I 
100  10 t 
1,000  10 I 
J7)'R8  10  104 
100  104 
1,000  nt 
J7"yR10  10  102 
100  103 
1,000  103 
Cell clones were incubated for 21 h in the presence or absence of the concentra- 
tion of IFN-',/ indicated.  Each concentration  was assayed in duplicate  wells. 
Cells were then infected with VSV for 24 h after which the supernatants were 
assayed  for viral yields.  The results  are presented  as the reduction  of viral 
yields when comparing a clone treated with IFN-,y with the same clone growing 
in medium alone. The titer of virus for the J774.2  and variant clones growing 
in medium alone was 1-5  x  107 pfu[ml, nt,  not tested. 
(Table II). The existence of mutants of these diverse pheno- 
types provides firm genetic evidence that the antiviral and 
antiproliferative effects of IFN--~ can be dissociated (summa- 
rized in Table III). Thus, there must be a divergence of the 
intracellular responses to IFN-'t beyond the receptor level al- 
lowing the antiviral and antiproliferative effects  to be  in- 
dependently regulated within the cells. 
Mechanism of  Inhibition of Viral Replication by IFN-~ 
The molecular mechanisms responsible for the antiviral 
effects of  IFNs are not fully  understood in any system, least 
of all for IFN--y. With the possibility that our somatic cell 
mutants could provide insight into this important issue, the 
mutants defective in their antiviral response to IFN-q¢ were 
analyzed for the two known biochemical markers previ- 
ously implicated in the antiviral actions of  IFN-c~ and -13. A 
Table II. Reduction in Viral Yields in Parental and 
Variant Clones in Response to IFNs 
J774.2  J7-yR5  J73,R1  J774.2-7 
Type of lFN  VSV  EMCV  VSV  EMCV  VSV  EMCV  VSV  EMCV 
IFN-"/  104  10  ~  <101  105  104  103  <10  ~  10 t 
IFN-tx  106  106  104  105  104  103  106  104 
Viral  yields were determined  as described  in Table  I, in response  to IFN-3" 
(1,000  IU/ml) and IFN-t~ (500 IU/ml). 
Table IlL Dissociation  of the Antiviral and Antiproliferative 
Effects of  lFN-'y 
Growth  Reduction of VSV 
Clone  Phenotype  inhibition  yields 
%  pfu/ml 
J774.2  Gi/V  p  85  104 
J7-/R5  Gr/v  ~  0  <10  t 
J73'R1  Gr/V  p  0  104 
J774.2-7  Gi/W  s  90  <101 
Growth inhibitory effects of IFN-3' were derived  from data in Figs.  1 and 2. 
Data for reduction of VSV yields were derived  from Tables I and II. 
P1/elF-2u protein kinase, in the presence of dsRNA, au- 
tophosphorylates itself  and subsequently eukaryotic initia- 
tion factor-2, preventing the recycling of elF-2o~ which 
thereby inhibits polypeptide chain initiation. In contrast to 
the significant  P1/elF-2ct protein kinase activity induced by 
IFN-3, in the parental J774.2  line, the Gi/V  s variant ex- 
hibited no demonstrable P1/elF-2ot protein kinase activity, and 
the Gr/V  s variant showed a diminished, but reproducible level 
of activity (Fig.  3).  The GqVp (growth resistant, but an- 
tivirally  protected  by IFN--y) cell line had similar P1/elF-2t~ ki- 
nase activity as the parental line, indicating that long-term 
growth of these cells in IFN-3, does not nonspecifically de- 
press enzyme activity (Fig. 4). Two explanations for the lack, 
or decrease, in the G~/V  s and GqV' variants, respectively, of 
P1/elF-2ct protein kinase  activity, were considered. One possi- 
bility is that the mutant selected is a variant containing  a defec- 
tive P1/elF-2a protein kinase. Alternatively, it is possible that 
only the regulation of  the kinase by IFN-3, is defective, the en- 
zyme itself being fully functional. To distinguish between 
these two possibilities, we examined whether IFN-a could in- 
duce the antiviral state in these sets of  variants. Since the same 
variants, summarized in Table II, were protected against VSV 
and EMCV infection  by IFN-ct, it was possible critically  to test 
whether the Gi/V s  and GqV  s variants were capable of  produc- 
ing a functional dsRNA-dependent P1/elF-2ot protein kinase 
in response to IFN-a. The results indicated that the G~/V  ~  and 
Gr/V  s variants had an equal or greater amount of P1/elF-2t~ 
protein kinase activity after IFN-ct treatment as compared the 
parental clone (Figs. 5 and 6), indicating that the lack of an- 
tiviral activity in response to IFN-q/is most likely due to a de- 
fect in its regulation by IFN-% 
The second biochemical mechanism associated with an- 
tiviral activity is the induction of the dsRNA-dependent 2'5'- 
(A), synthetase activity by the IFNs.  This enzyme, in the 
presence of dsRNA, converts ATP into a 2',5'-(A)o that acti- 
vates a latent endonuclease capable of degrading viral RNA. 
The spectrum of results in our variants followed a pattern 
very similar to that obtained in P1/elF-2a protein kinase ac- 
tivity. While the parental line showed a 22-fold induction of 
2',5'-(A)n  synthetase activity in  response  to  IFN-3,  treat- 
ment, the G~/V  s variant lacked any detectable 2',5'-(A)n syn- 
thetase activity above  background levels, while the GqV s 
variant had an approximately twofold higher basal level of 
2',5'-(A)n synthetase activity and a  twofold increase above 
this level after IFN-3~ treatment (Table IV). The Gr/V  p vari- 
ant had a similar increase in 2',5'-(A)n synthetase activity in 
response to IFN-q~ as the parental line. Interestingly, this 
variant had a fourfold higher basal level of 2',5'-(A),  synthe- 
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system in cell extracts of parental (J774.2, GqVp) 
and  variant  clones  (J7yRS, G~/V~; J774.2-7, 
G~/Vs). Cells were incubated for 21 h in the ab- 
sence or presence of IFN-,y (1,000 IU/ml) as indi- 
cated.  Postmitochondrial  cell extracts  were pre- 
pared  and  incubated  with  ['y-32p]ATP in  the 
presence (even lanes) or absence (odd lanes) of  2.0 
#g/ml poly(I):poly(C)  (dsRNA). The labeled pro- 
teins were analyzed by 10% SDS-PAGE. The posi- 
tions and the molecular masses (kD) of  the protein 
markers are indicated. The arrow points to the po- 
sition of the protein  P1 autophosphorylation.  An 
autoradiogram  of the dried  gel is shown. 
tase activity as compared with the parental line. Again, to 
differentiate whether the Gi/V  ~  and Gr/V  s variants contained 
a  structural defect in the 2',5'-(A). synthetase or was defec- 
tive in their regulation by IFN--y, the induction of 2',5'-(A)n 
synthetase activity after IFN-c~ treatment was measured. The 
2',5'-(A)o  synthetase  activity  induced  by  IFN-a  in  these 
variants was fully comparable to that of the parental cell line, 
indicating again that there is a defect in the regulation of this 
enzyme by IFN-3, (Table IV). The results derived from the 
G~/V  ~ variant implicate for the first time a common regula- 
tory  pathway  inducing  both  the  2',5'-(A).  synthetase  and 
P1/dF-2o~ protein kinase activities by IFN-ff, which must be 
distinct from both the pathway involved in regulating the an- 
tiproliferative effects mediated by IFN-3,, as well as the path- 
way involved in the antiviral response mediated by IFN-ot. 
These results are consistent with the possibility that IFN--~ 
and IFN-ot may use the same effector mechanisms to induce 
the antiviral state in J774.2 cells, and that only the regulation 
of these enzymes by IFNs differs. 
To further delineate the nature of the defects in the G~/V  ~ 
and Gr/V  ~  variants, induction of 2',5'-(A), synthetase mRNA 
levels in response to the IFNs were measured. Northern blot 
analysis after induction with IFN-3, for 8 h revealed that the 
2',5,'-(A)n  synthetase mRNA levels in the Gr/V  s variant was 
comparable to the parental clone (Fig. 7). Interestingly, IFN- 
~/did  not induce 2',5'-(A)n  synthetase mRNA levels in the 
GitV  s variant.  Thus,  the nature of the defects in the Gi/V  s 
and  Gr/V  s variants  are  different,  involving possibly  tran- 
scriptional and posttranscriptional processes, respectively. 
Mechanisms of  AnU'proliferative Effects 
of lFN-  7 and IFN-ol 
If  IFN-7 and IFN-. mediate their antiproliferative effects via 
different pathways, one might expect to find significant differ- 
ences in their kinetics of action and dose-response curves. 
Therefore,  we compared the  sensitivity of J774.2  cells to 
the antiproliferative and antiviral effects of both IFN-3, and 
IFN-ot. The antiproliferative and antiviral effects of IFN-cx 
were dose dependent,  but  100-1,000-fold greater amounts 
were required to inhibit cell growth than to engender the an- 
tiviral state (Fig.  1). In contrast, the concentration of IFN--/ 
required maximally to induce cells for the antiviral state was 
sufficient completely to arrest growth of the cells. Further, 
a kinetic difference exists between the two IFNs, in that IFN- 
q~-mediated  effects appear only after 18-20 h,  allowing the 
cells to divide at least once, whereas IFN-ot can prevent the 
cells from dividing. These data are most consistent with the 
interpretation that the antiproliferative effects of IFN-o~ and 
IFN--y are mediated by separate pathways. 
A more rigorous genetic approach was undertaken to ex- 
plore this question. We have previously reported that the an- 
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tracts of the Gr/V  v (J7,yR1)  variant. Cells were incubated for 21 h 
in the absence or presence of IFN-3, (1,000 IU/ml), or IFN-c~, as 
indicated. Postmitochondrial cell extracts were prepared and in- 
cubated with [3,-32P]ATP  in the presence (even lanes) or absence 
(odd lanes) of  2.0 #g/ml poly(I) :poly(C). The labeled proteins were 
analyzed by  10%  SDS-PAGE. The positions and the molecular 
masses (kD) of the protein markers are indicated. The arrow points 
to the position of  the protein P1 autophosphorylation. An autoradio- 
gram of the dried gel is shown. 
Discussion 
Three different classes of variants in the J774.2 macrophage 
cell line defective in their responses to IFN-3, have been de- 
rived from these studies (summarized in Table V). From a 
careful analysis of their phenotypes, we believe that several 
inferences regarding the regulatory mechanisms by which 
interferons act on these cells can be drawn.  (a) IFN-c~ and 
IFN-~/  mediate their antiproliferative activity via different 
signaling  mechanisms.  (b)  The  antiproliferative effect of 
IFN-3,,  in contrast to IFN-o~, is mediated by a cAMP inde- 
pendent pathway in these cells. (c) The mechanisms of the 
antiproliferative and antiviral activities of IFN-3, can be ge- 
netically dissociated. (d) dsRNA-dependent P1/elF-2a pro- 
tein kinase and 2',5'-(A). synthetase, induced by both IFN-a 
and IFN--},, may be involved in the antiviral effects against 
at least some RNA viruses, but the regulation of these en- 
zymes by the different IFNs is mediated by different path- 
ways.  (e)  The  antiviral  mechanisms  induced  by  IFN-  7 
against VSV and EMCV have been genetically dissociated, 
and must be distinct at some level. 
By way of commentary, it is not suprising that the seem- 
ingly similar antiproliferative response to IFN-a and IFN-~/ 
in the same cloned cell line could be mediated via different 
regulatory signals.  A  wide variety of growth factors, hor- 
mones,  lymphokines,  and  differentiation-inducing  factors 
are known to act on the same structural gene by regulatory 
pathways involving different second messengers and trans- 
acting factors. For example, metaUothionein genes are regu- 
lated by such diverse agents as the glucocorticoids, zinc and 
cadmium  ions,  cAMP,  TPA,  and  IFN-a,  through distinct 
tiproliferative effects of IFN-ot on the J774.2 cell line was 
cAMP dependent (32, 39). To test whether the same was true 
for the IFN-  3, antiproliferative effects, cholera toxin-resis- 
tant  clones  were  tested  for  their  sensitivity  to  IFN-3,- 
mediated growth inhibition.  Cholera toxin-resistant clones 
have been previously shown to be defective in adenylate cy- 
clase,  and were found here to be fully sensitive to the an- 
tiproliferative effects of IFN-3, (Fig. 8 B). Furthermore, all 
the IFN-'t growth-resistant variants remain fully susceptible 
to growth inhibition by cholera toxin (Fig. 8 A), These results 
provide formal genetic evidence that the antiproliferative re- 
sponse of J774.2 induced by IFN-3~ is cAMP independent. 
Finally, we examined whether the IFN--y growth-resistant 
variants were sensitive or resistant to IFN-ot-mediated an- 
tiproliferative effects. All of the IFN-~ growth-resistant mu- 
tants were fully sensitive to the antiproliferative effects of 
IFN-ot (Fig. 2). These results provide genetic evidence that 
IFN-3, and IFN-a  elicit antiproliferative responses in  the 
J774.2 cell line through different signaling pathways. 
Figure 5. Assay of P1/elF-2ot protein kinase activity in cell extracts 
of parental (J774.2, C¢/VP) and variant clone (J774.2-7, G~/V~). 
Ceils were incubated for 20 h in the presence or absence of IFN-c~ 
(200 IU/ml) and assayed as in Fig. 3. 
The Journal of Cell Biology, Volume 109,  1989  1336 Figure 6.  Assay of P1/elF-2a protein kinas¢ activity in 
cell  extracts of parental (.I774.2, C¢/Vv) and  variant 
clone (JT"tRS, G~/V~). Ceils were incubated for 20 h in 
the presence or absence of IFN-ct (500 IU/ml) and as- 
sayed as in Fig. 3. 
regulatory sequences in the 5' region of the gene (reviewed 
in 21). The proenkephaiin gene has been shown to be tran- 
scriptionally activated by both the adenylate cyclase pathway 
via cAMP, as well as the phosphatidylinositol pathway via 
protein kinase C (11). Interestingly, the DNA sequences re- 
quired for the regulatory effects for both cAMP and phorbol 
esters  mapped to the  same  37-bp 5' region of the human 
enkephalin  gene.  In  bone  marrow-derived  macrophages, 
CSF-1 has been reported transiently to induce c-fos mRNA 
levels via phospholipid degradation, protein kinase C activa- 
tion, and Ca  z+ mobilization (6).  Of particular interest, be- 
cause  of our  previous  finding that  IFN-ot  exerts  its  an- 
tiproliferative effects in J774.2  macrophage cell  lines  via 
intracellular cAMP,  it was similarly shown that dibutyryl 
cAMP or cholera toxin could lead to the stable induction of 
c-fos transcription in these same bone marrow macrophages. 
In this regard, we have preliminary genetic evidence indicat- 
ing that the antiproliferative response of mouse macrophages 
to IFN-,y is mediated through a protein kinase C-dependent 
Table IV. Induction of  2',5'-Oligoadenylate  Synthetase 
Activity after IFN Treatment 
2',5' Oligoadenylate synthetase activity* 
Clone  Phenotype  Control  IFN--y  IFN-ct 
1,000 IU/ml  1,000 lU/ml 
J774.2  Gi/V  p  3.5  101.5  186.7 
J7"/R5  G~/V  s  8.0  18.6  149.9 
J7),RI  Gr/V  p  14.3  102.5  336.7 
J774.2-7  GI/V  ~  2.0  4.2  200.7 
* Nanomoles ATP converted per milligram protein. Results are presented as 
the average 2',5'(A), synthetase activity derived from two independent experi- 
ments except for the IFN-~,-treated  J7"tR5 clone and the IFN-a-treated J7-yRl 
clone in which the results represent a  single experimental value, 
pathway (Goldberg, M., L. S. Belkowski, and B. R. Bloom, 
manuscript submitted for publication). It will be fundamen- 
tally important to establish whether IFN-3,  and IFN-ot are 
using different signals to exert regulatory effects on the same 
effector genes that mediate the antiproliferative effects, e.g., 
transcriptionally inactivating the same proto-oncogenes, or 
whether IFN-a and IFN-3, affect the expression of distinct 
genes that lead to a common growth inhibitory effect. 
The  second  question addressed  in  this  work  concerns 
whether different pathways were responsible for mediating 
the different biological responses  to IFN-~  in the mouse 
macrophage cell line. We had previously derived variants 
that were resistant to the antiproliferative effects of IFN-c~, 
and found them to be fully protected against lysis by VSV 
(33). In similar experiments, we have been able genetically 
to dissociate the antiviral and antiproliferative effects of  IFN- 
-y by isolating variants specifically unresponsive to one, but 
not the other of these effects. Our results suggest for the first 
time the possibility that a common molecule regulates both 
the P1/eIF-2a  protein  kinase and the 2',5'-(A).  synthetase 
activities that must be distinct from molecules involved in 
regulating  the  antiproliferative  responses  to  IFN-%  The 
G~/V  s variant fails to show induction of both of these enzy- 
matic activities after treatment with IFN-% even though the 
enzymes themselves are fully functional, as indicated from 
the induction of their activity by IFN-o~. At what point does 
the bifurcation of the cellular responses to IFNs occur? The 
available evidence indicates the existence of a single biologi- 
cally functional high affinity  receptor for IFN-~ on many eel] 
types including macrophages (1, 8), with which our prelimi- 
nary Scatchard data on J774.2 are consistent. The receptor 
molecule itself  could conceivably mediate different  effects by 
binding to regulatory regions of  different  genes, as is the case 
for the glucocorticoid receptor (2); or, the different biologic 
effects could diverge subsequent to binding and triggering of 
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(A). synthetase mRNA in pa- 
rental and variant clones. Cells 
were incubated in the absence 
or presence of 500 IU/ml of 
IFN-3, for 8.5 h. Cytoplasmic 
RNA was isolated  and analyzed 
via  Northern  blot  analysis. 
The Biodyne blot was hybrid- 
ized with a riP-labeled ribo- 
probe of the human 2',5'-(A). 
synthetase  gene. An autoradio- 
gram of the hybridized blot is 
shown.  Lanes  1-4  and  5-8 
are results from two different 
Northern  blots,  respectively, 
that were combined to form a single figure. Exposure times for the two blots were normalized to equal intensity of the IFN-3,-induced 
2;5'-(A), synthetase mRNA transcript in the parental line. The arrow points to the 2',5'-(A),  synthetase mRNA transcript. 
the receptor, for example, by generating transducing factors 
that regula  R different genes in different ways.  Evidence on 
a human macrophage cell line, U937 cells;:indicates clearly 
that transcriptional activation of IFN-7-inducible genes can 
occur by at least two separate pathways, protein kinase C de- 
pendent and independent (14).  Further, cycloheximide can 
block the transcriptional induction of only a subset of IFN-o~ 
and IFN-~-induced genes implicating multiple pathways by 
which the IFNs exert their regulatory control (7, 13, 16, 29). 
From several studies on gene regulation by IFN-, and IFN- 
/~, transcriptional regulatory regions of IFN-inducible genes 
appear to be necessary, but not fully sufficient for the regula- 
tory  effects induced  by  the  IFNs.  For  example,  IFN-ot- 
inducible  genes  contain  homologies  in  their  5'  flanking 
regulatory regions (10, 15, 37, 40, 41), although the cytoplas- 
mic mRNA levels for some of these genes is determined by 
posttranscriptional mechanisms (16, 25). It is not yet clear 
at what level IFN-7 regulates the 2',5'-(A). synthetase and 
P1/eIF-2o~ protein kinase enzymatic activity in the J774.2 
cells. 
20[  A  '° F B 
:I  l:I  ~-,4  f 7 
~6  ~3 
-~,cT  rCT  ~,CT ~'CT ~,CT 
J~T4.~ J~×*, Jr,,R5 JTrV J~r*a Jlrl,o  ,r74.2  CTRC~ CT~¢~ CT~ CT*~S 
Figure 8.  Growth of parental and variant clones in the absence 
(hatched bar) and presence of IFN-3, (1,000 U/ml, solid bar) and 
cholera toxin (250 ng/ml, open bar). Results are presented as the 
average number of  counts per minute from triplicate wells. (A) IFN- 
~-resistant clones  were  seeded with 2  ×  103 cells/0.15 ml and 
pulsed with tritiated thymidine at 80 h. (B) Cholera toxin-resistant 
clones  were seeded at 7.5  ×  103 cells/0.15 ml and pulsed with 
tritiated thymidine at 65 h. 
Our attempts to clarify the molecular mechanisms respon- 
sible for the antiviral effects of  the two classes oflFN in these 
experiments presented an unexpected finding regarding the 
specificity of antiviral  mechanisms  for different RNA  vi- 
ruses.  It has long been known that there are differences in 
both kinetics and mode of action in the induction of the an- 
tiviral state by IFN-~ and IFN-cc IFN-ct generally requires 
a  shorter time to induce the antiviral state than IFN-% the 
thought being that IFN-~,  requires more than one round of 
protein synthesis to induce the antiviral state (3, 12). The Mx 
gene product involved in natural resistance to influenza in- 
fection in  mice is  specifically induced by IFN-ct,  but not 
IFN-), (45). On the other hand, it appears that adenoviruses 
can be inhibited by IFN-  7,  but not IFN-ct (30).  While we 
have no formal proof that the antiviral effects of IFN-3, are 
mediated through dsRNA-dependent P1/elF-o~  protein kinase 
or 2',5'-(A)n  synthetase, our results are consistent with the 
interpretation that either or both of those pathways may be 
involved in  resistance  to  VSV  and  EMC  replication,  al- 
though our data would suggest that IFN-c~ and IFN-~, must 
utilize different pathways to regulate these genes. 
Throughout the interferon literature, correlations between 
the antiviral state and enzymatic activities of 2',5'-(A), syn- 
thetase and P1/elF-2o~ protein kinase induced by IFNs repre- 
sent a major theme. For example, the role of the P1/elF-2a 
protein  kinase  system  in  the  antiviral  response has  been 
strengthened from the analysis of adenoviruses and vaccinia 
viruses that have devised strategies to overcome the activity 
of the  P1/elF-2ct  protein kinase  system  (22,  44,  51,  52). 
Strong support for a role of the 2',5'-(A), synthetase derives 
from transfection studies in Chinese hamster ovary (CHO) 
cells. High constitutive expression of the 2',5'-(A), synthe- 
tase correlated to resistance to infection by a picornavirus 
such as mengo, but not to the rhabdovirus, VSV (9). Consis- 
tent with this general view, the J774.2-7 variant,  which is 
fully growth inhibited by IFN-3,,  exhibited no demonstrable 
P1/elF-2ot protein kinase activity or 2',5'-(A), synthetase ac- 
tivity after IFN-3/treatment, and was not protected against 
VSV or EMCV. Our genetic evidence is corroborated by bio- 
chemical data  that  shows  IFN-7  completely inhibits VSV 
protein synthesis in the J774.2 cell line (data not shown). 
This finding contrasts to a report that implicates primarily 
a posttranslational step in the IFN-3~-induced  antiviral activ- 
The Journal  of Cell Biology,  Volume 109, 1989  1338 Table V. Summary of  Parental and Variant Clone Phenotypes 
Induction of the 
antiviral state 
Growth inhibition  IFN3,  IFNa 
Clone  Phenotype  IFN~  IFNct  C.T,  VSV  EMCV 
2',5' Oligoadenylate 
synthetase  and 
elF-2 kinase activities 
VSV  EMCV  IFN~  IFNc~ 
J774.2  Gi/V  p  +  +  +  +  + 
J774.2-7  GI/V  ~  +  +  +  -  - 
J73'R1  Gr/V  p  -  +  +  +  -F 
J73'R5  Gr/V  s  -  +  +  -  + 
+  +  +++  ++++ 
+  +  --  ++++ 
+  +  +++  ++++ 
+  +  +  ++++ 
ity in a human  amniotic cell line (48, 49),  raising the un- 
happy possibility that the antiviral  effects of IFNs may be 
mediated by distinct molecular mechanisms in different cell 
types. 
Another mutant defective in the IFN--/-mediated antiviral 
response presents a unique phenotype. This variant, J7~,R5, 
is resistant to the antiproliferative effects of IFN--y and is pro- 
tected against viral lysis caused by EMC virus, but not by 
VSV.  This variant exhibits a small, but consistently detect- 
able level of P1/elF-2ot protein kinase activity and 2',5'-(A), 
synthetase activity induced by IFN-% A similar variant has 
been  described  in  a  human  rhabdomyosarcoma  cell  line 
which is protected by human IFN-7 against EMCV, but not 
VSV (26).  Constituitive expression of the cDNA encoding 
the 40-kD 2',5'-(A), synthetase recombinant protein in CHO 
cells resulted in reconstitution of resistance against a related 
picornavirus, mengo virus, but not VSV (9). The mechanism 
for this differential sensitivity of EMCV and mengo virus rel- 
ative to VSV is unclear,  although qualitative differences in 
mechanisms of replication of positive stranded viruses, such 
as EMC or mengo, relative to a negative-stranded virus, like 
VSV, may be important.  Alternatively, the mutation that al- 
lowed this variant to grow in the presence of IFN-3, may also 
permit the transcriptional activation of the VSV genome, but 
not of the  EMCV  genome.  Indeed,  there is evidence that 
tubulin and microtubular-associated  proteins can stimulate 
VSV  transcription  in  vitro  (19,  31).  Curiously  the J7qcR5 
variant,  unlike the parental  line,  falls to undergo any mor- 
phologic changes in the presence of IFN-% and only poorly 
adheres to surfaces after treatment with IFN-3,. 
Finally, we hope that the macrophage variants described, 
in addition  to facilitating  analysis of differential  signalling 
pathways and possible effector mechanisms involved in cellu- 
lar responses to IFNs, may provide unique possibilities for 
isolating  genes  encoding  important  effector  proteins  and 
trans-acting regulatory factors involved in interferon action. 
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